Year: 2026
Type: preprint
Study design: Case Report
Abstract: Introduction. Myxofibrosarcoma, previously termed the myxoid subtype of malignant fibrous histiocytoma, is a rare malignant neoplasm of the craniofacial skeleton, particularly the mandible. Its rarity results in limited data regarding clinical features, therapeutic approaches, and long-term outcomes. Patient Concerns. A 40-year-old male presented with a three-month history of a painless, progressively enlarging gingival mass in the right mandibular region, with ulceration in the gingivobuccal sulcus. Diagnosis. Panoramic radiography and FDG-PET/CT revealed a fluorodeoxyglucose-avid, ill-defined lytic lesion involving the right alveolar process with extension into the retromolar trigone, mandibular foramen, and mandibular canal. Incisional biopsy combined with histopathology and immunohistochemistry (vimentin +, CD31 +; CK-AE1/AE3, S-100, P63, HMB-45, desmin, synaptophysin negative; Ki-67 ~ 30%) confirmed high-grade epithelioid myxofibrosarcoma. Interventions. The patient underwent right hemimandibulectomy via a submandibular incision with a circumferential 2-cm surgical margin and reconstruction using a pectoralis major myocutaneous flap, followed by adjuvant chemotherapy and adjuvant radiotherapy (60 Gy in 30 fractions). Outcomes. Postoperative recovery was uneventful. The patient was discharged on postoperative day 7, transitioned to oral feeding by day 10, and remains disease-free at 20 months of follow-up. Conclusion. Mandibular MFS is extremely rare. Wide surgical resection with negative margins combined with multimodal adjuvant therapy and vigilant long-term follow-up remains the mainstay of curative management.
Source: Research Square
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7236058514
